Docteur FREDERIQUE NAVAUX

Lieu de consultation

• CH PERPIGNAN

  20 Avenue DU LANGUEDOC, 66046 Perpignan

  ☎ 0468616633Hospitalier🏥 Centre CH ↗🏥 Voir cet établissement

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis

  Arthritis and rheumatism · 1999

  📚 222 citations🎯 RCR 5.74Top 6% NIH
• 2

  Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study

  Arthritis and rheumatism · 2002

  📚 49 citations🎯 RCR 1.22

  Lire l'abstract Crossref ↓

  AbstractObjectiveTo test the hypothesis of an association between a polymorphism in the matrix metalloproteinase 3 (MMP‐3) gene promoter and the susceptibility, severity, and progression of rheumatoid arthritis (RA), and to further document the association between HLA–DRB1 alleles encoding the shared epitope (SE) and the severity and progression of RA.MethodsPatients with early RA (n = 103) were included in this prospective study. A total radiographic damage score (TDS; by the Sharp/van der Heijde method) was used to quantify RA severity at baseline and after 4 years of followup. The 5A/6A biallelic polymorphism in the MMP‐3 gene promoter was analyzed using fluorescence‐based polymerase chain reaction (PCR). HLA–DRB1 genotyping was performed using PCR methods. Control subjects (n = 127) were unrelated healthy individuals.ResultsMMP‐3 allele carriage rates and allele and genotype frequencies did not differ between patients and controls. The MMP‐3 6A/6A genotype was associated with the highest TDS both at baseline and after a 4‐year followup and with the highest progression of the TDS over the 4 years of followup. The DRB1 SE+/+ genotype was associated with the highest TDS after a 4‐year followup and with the highest progression of the TDS over the 4 years of followup. Patients homozygous for MMP‐3 6A and DRB1 SE had the highest progression of the TDS.ConclusionThis study provides the first evidence of an association between a polymorphism in the MMP‐3 gene promoter and the severity and progression of RA, but not RA susceptibility. Investigation of this polymorphism could be combined with that of DRB1 gene polymorphism to improve the predictive accuracy and management strategy in early RA.

• 3

  Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis

  Clinical and experimental rheumatology · 2004

  📚 29 citations🩺 Clinique

Publications scientifiques (7) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche